Hiroki Kobayashi

3.1k total citations
100 papers, 1.2k citations indexed

About

Hiroki Kobayashi is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Hiroki Kobayashi has authored 100 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 25 papers in Endocrinology, Diabetes and Metabolism and 24 papers in Molecular Biology. Recurrent topics in Hiroki Kobayashi's work include Hormonal Regulation and Hypertension (18 papers), Adrenal and Paraganglionic Tumors (15 papers) and Adrenal Hormones and Disorders (10 papers). Hiroki Kobayashi is often cited by papers focused on Hormonal Regulation and Hypertension (18 papers), Adrenal and Paraganglionic Tumors (15 papers) and Adrenal Hormones and Disorders (10 papers). Hiroki Kobayashi collaborates with scholars based in Japan, United States and Australia. Hiroki Kobayashi's co-authors include Masanori Abe, Makoto Asashima, Ryuichi Nishinakamura, Kiyoshi Kawakami, Masayoshi Soma, Sho Tanaka, Noboru Fukuda, Mitsuhide Naruse, Kazuyoshi Okada and Noriaki Maruyama and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Hiroki Kobayashi

91 papers receiving 1.2k citations

Peers

Countries citing papers authored by Hiroki Kobayashi

Since Specialization

Citations

This map shows the geographic impact of Hiroki Kobayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Kobayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Kobayashi more than expected).

Fields of papers citing papers by Hiroki Kobayashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Kobayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Kobayashi. The network helps show where Hiroki Kobayashi may publish in the future.

Co-authorship network of co-authors of Hiroki Kobayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Kobayashi. A scholar is included among the top collaborators of Hiroki Kobayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Kobayashi. Hiroki Kobayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A case of bilateral adrenal infarction with preserved adrenal function diagnosed by dual-energy computed tomography 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Masahiro Nishihara, Hideki Nakamura, (unknown), Hiroki Kobayashi, Masanori Abe, Masahiro Okada	0
2	Integrated analysis of blood DNA methylation, genetic variants, circulating proteins, microRNAs, and kidney failure in type 1 diabetes 2024 ·Science Translational Medicine ·Zhuo Chen, Eiichiro Satake, Marcus G. Pezzolesi, Zaipul I. Md Dom, (unknown), Hiroki Kobayashi, Anna Syreeni, (unknown), Xiwei Wu, Emma H. Dahlström, (unknown), Per‐Henrik Groop, Stephen S. Rich, Niina Sandholm, Andrzej S. Królewski, Rama Natarajan	8
3	Iron Metabolism and Inflammatory Mediators in Patients with Renal Dysfunction 2024 ·International Journal of Molecular Sciences ·(unknown), Masanori Abe, Hiroki Kobayashi	14
4	Predictors of the effectiveness of first-line CTLA4-Ig in patients with RA: the FIRST registry 2024 ·Lara D. Veeken ·Hiroki Kobayashi, Yusuke Miyazaki, Shingo Nakayamada, Kentaro Hanami, Shunsuke Fukuyo, Satoshi Kubo, Ayako Yamaguchi, Yoshino Inoue, Yasuyuki Todoroki, (unknown), (unknown), Yoshihisa Fujino, Shintaro Hirata, Yoshiya Tanaka	1
5	Circulating proteins linked to apoptosis processes and fast development of end-stage kidney disease in diabetes 2024 ·JCI Insight ·(unknown), Eiichiro Satake, Parker C. Wilson, Bozena Krolewski, Hiroki Kobayashi, Zaipul I. Md Dom, (unknown), Jonathan M. Wilson, Jonathan M. Dreyfuss, Monika A. Niewczas, Alessandro Doria, Robert G. Nelson, Marcus G. Pezzolesi, Benjamin D. Humphreys, Kevin L. Duffin, Andrzej S. Królewski	3
6	Preanalytical considerations in quantifying circulating miRNAs that predict end-stage kidney disease in diabetes 2024 ·JCI Insight ·Eiichiro Satake, Bozena Krolewski, Hiroki Kobayashi, Zaipul I. Md Dom, (unknown), Jonathan M. Wilson, Dave S.�B. Hoon, Kevin L. Duffin, Marcus G. Pezzolesi, Andrzej S. Królewski	2
7	Classification of Predictors of Rapid Development of Kidney Failure and Short-Term Changes in Concentration of Circulating Proteins 2024 ·Clinical Journal of the American Society of Nephrology ·Hiroki Kobayashi, Helen C. Looker, (unknown), Zaipul I. Md Dom, Eiichiro Satake, Sok Cin Tye, Kevin L. Duffin, Alessandro Doria, Robert G. Nelson, Andrzej S. Królewski	0
8	Specific regulation of BACH1 by the hotspot mutant p53R175H reveals a distinct gain-of-function mechanism 2023 ·Nature Cancer ·Zhenyi Su, Ning Kon, Jingjie Yi, Haiqing Zhao, Wanwei Zhang, Qiaosi Tang, Huan Li, Hiroki Kobayashi, Zhiming Li, Shoufu Duan, Yanqing Liu, Kenneth P. Olive, Zhiguo Zhang, Barry Honig, James J. Manfredi, Anil K. Rustgi, Wei Gu	36
9	Development of gene silencer pyrrole-imidazole polyamides targeting GSK3β for treatment of polycystic kidney diseases 2023 ·Journal of Pharmacological Sciences ·(unknown), Noboru Fukuda, Hiroki Kobayashi, Akiko Tsunemi, (unknown), Tarô Matsumoto, Masanori Abe	1
10	Primary pituitary lymphoma successfully treated with Bruton’s tyrosine kinase inhibitor monotherapy: case report 2023 ·(unknown), Tomonari Suzuki, Hiroki Sato, Hiroki Kobayashi, (unknown), Mitsuaki Shirahata, Tatsuya Ozawa, Kazuhiko Mishima	2
11	Ampelomyces strains isolated from diverse powdery mildew hosts in Japan: Their phylogeny and mycoparasitic activity, including timing and quantifying mycoparasitism of Pseudoidium neolycopersici on tomato 2021 ·PLoS ONE ·Márk Z. Németh, (unknown), Hiroki Kobayashi, Diána Seress, (unknown), Yutaka Kimura, Susumu Takamatsu, Tomoko Suzuki, Yoshihiro Takikawa, Koji Kakutani, Yoshinori Matsuda, Levente Kiss, Teruo Nonomura	13
12	Association of achieved blood pressure after treatment for primary aldosteronism with long-term kidney function 2021 ·Journal of Human Hypertension ·(unknown), Yuichiro Yano, Yu Hatano, Kouichi Tamura, Isao Kurihara, Hiroki Kobayashi, Mika Tsuiki, Takamasa Ichijo, Norio Wada, Takuyuki Katabami, Kōichi Yamamoto, Shintaro Okamura, Tatsuya Kai, Shoichiro Izawa, (unknown), Masanobu Yamada, (unknown), Akiyo Tanabe, Mitsuhide Naruse, (unknown)	4
13	Association between dysfunction of upper extremity and locomotive syndrome in general population 2016 ·Journal of Orthopaedic Science ·Tsuyoshi Tajika, Atsushi Yamamoto, (unknown), (unknown), (unknown), (unknown), Hiroki Kobayashi, Haku Iizuka, Kenji Takagishi	9
14	Late Anterior Dislocation Due to Posterior Pelvic Tilt in Total Hip Arthroplasty 2016 ·The Open Orthopaedics Journal ·Hiroki Kobayashi, Yasuharu Nakashima, Takuaki Yamamoto, Goro Motomura, Masayuki Kanazawa, Kenji Takagishi, Yukihide Iwamoto	24
15	Potential utility of HOP homeobox gene promoter methylation as a marker of tumor aggressiveness in gastric cancer 2010 ·Oncogene ·Akira Ooki, Keishi Yamashita, Shiro Kikuchi, (unknown), Natsuya Katada, Kenichi Kokubo, Hiroki Kobayashi, (unknown), David Sidransky, Masahiko Watanabe	64
16	Six1 and Six4 are essential for Gdnf expression in the metanephric mesenchyme and ureteric bud formation, while Six1 deficiency alone causes mesonephric-tubule defects 2007 ·Mechanisms of Development ·Hiroki Kobayashi, Kiyoshi Kawakami, Makoto Asashima, Ryuichi Nishinakamura	71
17	Identification and characterization of a novel Dvl‐binding protein that suppresses Wnt signalling pathway 2003 ·Genes to Cells ·Akihiko Oshita, Shosei Kishida, Hiroki Kobayashi, Tatsuo Michiue, Toshimasa Asahara, Makoto Asashima, Akira Kikuchi	54
18	GROBNER BASIS OF IDEAL OF CONVERGENT POWER SERIES 1986 ·Kyoto University Research Information Repository (Kyoto University) ·Hiroki Kobayashi, (unknown), Takeshi Sasaki	1
19	ON PERSISTENT HOMEOMORPHISMS 1985 ·Kyoto University Research Information Repository (Kyoto University) ·Kazuhiro Sakai, Hiroki Kobayashi	2
20	Genetic and morphological studies on congenital cataract and microphthalmia in mice. 1980 ·Congenital Anomalies ·Hiroki Kobayashi	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact